Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients

Author(s):
Heidt, S. (0000-0002-6700-188X); Haasnoot, G.W.; Witvliet, M.D.; Linden-van Oevelen, M.J.H. van der; Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Otten, H.G.; Roelen, D.L.; Claas, F.H.J.
Published
2019
Publication type
Article / Letter to editor
alloantibodyclinical researchpracticehistocompatibilityimmunogeneticskidney transplantationnephrologymajor histocompatibility complex (MHC)rejection
Date issued
2019-10-31
Language
English
Is part of
American Journal of Transplantation (2019), Vol. 19, no. 10, p. 2926-2933
hdl
1887/121201
doi
10.1111/ajt.15486